Clostridium innocuum infection in hospitalised patients with inflammatory bowel disease

被引:9
|
作者
Le, Puo-Hsien [1 ,2 ,3 ]
Chiu, Cheng-Tang [1 ,2 ]
Yeh, Pai-Jui [4 ]
Pan, Yu-Bin [5 ]
Chiu, Cheng-Hsun [6 ,7 ]
机构
[1] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Linkou Branch, Taoyuan, Taiwan
[2] Taiwan Assoc Study Small Intestinal Dis, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Liver Res Ctr, Linkou Branch, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Gastroenterol, Linkou Branch, Taoyuan, Taiwan
[5] Chang Gung Mem Hosp, Clin Trial Ctr, Linkou Branch, Biostat Sect, Taoyuan, Taiwan
[6] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Infect Dis, Linkou Branch, 5 Fu Hsin St, Taoyuan 333, Taiwan
[7] Chang Gung Mem Hosp, Mol Infect Dis Res Ctr, Linkou Branch, Taoyuan, Taiwan
关键词
Clostridium innocuum; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Vancomycin resistance; DIFFICILE; CARRIAGE; DIARRHEA;
D O I
10.1016/j.jinf.2021.12.031
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Clostridium innocuum (CI) infection can lead to creeping fat in Crohn's disease and is associated with intestinal strictures. At present, no clinical study ever has evaluated the role of CI infection in inflammatory bowel disease (IBD). Materials and methods: In this retrospective cohort study, we enrolled hospitalized IBD patients with culture results for both CI and Clostridioides difficile (CD) in a medical center between October 2019 and April 2021. They were divided into the CI (CI+/CD-), control (CI-/CD-), coinfection (CI+ /CD+), and CD (CI-/ CD+) groups. We analyzed the risk factors, clinical presentations, and outcomes by comparing the CI and control groups. Results: We enrolled a total of 90 patients, including 22, 39, 13, and 16 patients in the CI, control, co-infection, and CD groups. The incidence rates of CI (CI+) and CD (CD+) were 39% (35/90) and 32% (29/90), respectively. We analyzed the differences between CI and control groups. We identified the use of steroid (77.3% vs. 46.2%, P = 0.018) and 5-aminosalicylic acid (90.9% vs. 64.1%, P = 0.022) as risk factors of CI infection. Clinical analysis showed that more patients in CI group presented with bloody stool (77.3% vs. 51.3%, P = 0.046). Although CI group had significantly lower overall occurrence of intraabdominal abscess (0% vs. 17.9%, P = 0.042), it showed a lower clinical remission rate (50% vs. 87.5%, P = 0.044) and higher Mayo score at the end of follow-up (10 points vs. 3 points, P = 0.008) in ulcerative colitis. Conclusions: CI infection may lead to a poorer clinical remission in ulcerative colitis. We should take it into consideration in IBD patents with active inflamamtion or refractory diarrhea with or without CD infection. Precise identification of CI is imperative to guide approproate antimicrobial therapy because of its intrinsic vancomycin resistance nature. (C) 2021 Published by Elsevier Ltd on behalf of The British Infection Association.
引用
收藏
页码:337 / 342
页数:6
相关论文
共 50 条
  • [41] The Role of Intravenous Corticosteroids in Patients With Inflammatory Bowel Disease and Clostridium difficile Infection
    Liu, Kevin
    Bellaguarda, Emanuelle
    Gregory, Dyanna
    Hanauer, Stephen B.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S810 - S810
  • [42] Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease
    Zhang, Ting
    Lin, Qian-Yun
    Fei, Jia-Xi
    Zhang, Yan
    Lin, Min-Yi
    Jiang, Shuang-Hong
    Wang, Pu
    Chen, Ye
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [43] Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients
    Hughes, Michelle
    Qazi, Taha
    Berg, Adam
    Weinberg, Janice
    Chen, Xinhua
    Kelly, Ciaran P.
    Farraye, Francis A.
    [J]. INFLAMMATORY BOWEL DISEASES, 2016, 22 (04) : 853 - 861
  • [44] Clostridium Difficile Infection Worsen Outcome of Hospitalized Patients with Inflammatory Bowel Disease
    Ting Zhang
    Qian-Yun Lin
    Jia-Xi Fei
    Yan Zhang
    Min-Yi Lin
    Shuang-Hong Jiang
    Pu Wang
    Ye Chen
    [J]. Scientific Reports, 6
  • [45] Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease
    Horton, Henry A.
    Dezfoli, Seper
    Berel, Dror
    Hirsch, Julianna
    Ippoliti, Andrew
    McGovern, Dermot
    Kaur, Manreet
    Shih, David
    Dubinsky, Marla
    Targan, Stephan R.
    Fleshner, Phillip
    Vasiliauskas, Eric A.
    Grein, Jonathan
    Murthy, Rekha
    Melmed, Gil Y.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) : 5054 - 5059
  • [46] Clostridium Difficile Infection as a cause of severe outcomes in patients with Inflammatory Bowel Disease
    Fadeeva, N.
    Knyazev, O.
    Parfenov, A.
    Kagramanova, A.
    Lishinskaya, A.
    Babayan, A.
    Danilov, M.
    Dolgopyatov, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S273 - S273
  • [47] Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study
    Razik, Roshan
    Rumman, Amir
    Bahreini, Zoya
    McGeer, Allison
    Nguyen, Geoffrey C.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (08): : 1141 - 1146
  • [48] Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection
    Sokol, Harry
    Jegou, Sarah
    McQuitty, Claire
    Straub, Marjolene
    Leducq, Valentin
    Landman, Cecilia
    Kirchgesner, Julien
    Le Gall, Guillaume
    Bourrier, Anne
    Nion-Larmurier, Isabelle
    Cosnes, Jacques
    Seksik, Philippe
    Richard, Mathias L.
    Beaugerie, Laurent
    [J]. GUT MICROBES, 2018, 9 (01) : 55 - 60
  • [49] Rifaximin and treatment of recurrent Clostridium difficile infection in patients with inflammatory bowel disease
    Issa, Mazen
    Weber, Lydia R.
    Brandenburg, Heather
    Emmons, Jeanne
    Skaros, Sue
    Knox, Josh F.
    Beaulieu, Dawn B.
    Binion, David G.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S469 - S469
  • [50] Recurrence of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease - The RECIDIVISM Study
    Razik, Roshan
    Rumman, Amir
    Bahreini, Zoya
    McGeer, Allison
    Nguyen, Geoffrey C.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S115 - S115